Thus, according to the levels of endogenous Shh in NSCLC cells, Shh pathway may be in a saturated state that does not allow detecting an additional activation of the pathway in the presence of exogenous Shh. The gene discussed is SHH; the disease is non-small cell lung carcinoma.